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Abstract
Background:  A majority of bacterial genes belong to tight clusters and operons, which
complicates gene functional studies using conventional knock-out methods. Antisense agents can
down-regulate the expression of genes without disrupting the genome because they bind mRNA
and block its expression. However, it is unclear how antisense inhibition affects expression from
genes that are cotranscribed with the target.
Results: To examine the effects of antisense inhibition on cotranscribed genes, we constructed a
plasmid expressing the two reporter genes gfp and DsRed as one transcriptional unit. Incubation
with antisense peptide nucleic acid (PNA) targeted to the mRNA start codon region of either the
upstream gfp or the downstream DsRed gene resulted in a complete expression discoordination
from this artificial construct. The same approach was applied to the three cotranscribed genes in
the endogenously expressed lac-operon (lacZ,  Y  and  A) and partial downstream expression
coordination was seen when the lacZ start codon was targeted with antisense PNA. Targeting the
lacY mRNA start codon region showed no effect on the upstream lacZ gene expression whereas
expression from the downstream lacA gene was affected as strongly as the lacY gene. Determination
of lacZ and lacY mRNA levels revealed a pattern of reduction that was similar to the Lac-proteins,
indicating a relation between translation inhibition and mRNA degradation as a response to
antisense PNA treatment.
Conclusion: The results show that antisense mediated repression of genes within operons affect
cotranscribed genes to a variable degree. Target transcript stability appears to be closely related
to inhibition of translation and presumably depends on translating ribosomes protecting the mRNA
from intrinsic decay mechanisms. Therefore, for genes within operons and clusters it is likely that
the nature of the target transcript will determine the inhibitory effects on cotranscribed genes.
Consequently, no simple and specific methods for expression control of a single gene within
polycistronic operons are available, and a thorough understanding of mRNA regulation and stability
is required to understand the results from both knock-down and knock-out methods used in
bacteria.
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Background
Antisense agents are useful for functional genomics in
bacteria as they can down-regulate expression of specific
genes by binding mRNA and inhibit translation. As anti-
sense agents may be titrated into cultures of wild type cells
they are attractive for studies of any gene, even those strin-
gently required for survival. Also, down-regulation
through externally added antisense agents bypasses the
need for genome modifications, thereby allowing gene
specific studies of both clustered and overlapping genes. A
remaining question, however, is whether antisense agents
retain specific inhibitory effects when cotranscribed genes
are targeted.
Prokaryotic genes are commonly expressed as polycis-
tronic transcripts. For E. coli, several concordant studies
predict that the >4400 genes are expressed as 2500–2800
transcriptional units (TUs) of which 70–75% are expected
to be monocistronic [1-3]. Therefore, over half of the E.
coli genes are expressed from multigene operons. Simi-
larly, predictions performed on various other prokaryotic
genomes show that between 27 and 78% of the genes are
expressed within polycistronic transcripts, with an average
well above 50% [2]. As a practical consequence, reliable
single ORF genetic knock-out techniques are difficult or
unavailable for functional genomics studies on a majority
of prokaryotic genes.
We are interested in the use of antisense peptide nucleic
acid (PNA) for functional genomics as well as antibacte-
rial drug discovery. PNA is a nucleic acid mimic with the
phosphodiester backbone replaced with pseudo-peptides
and can bind to other nucleic acids with high affinity [4].
PNA targeted specifically to mRNA results in inhibition of
gene expression, but unlike many other synthetic nucleic
acids PNA does not induce RNase H mediated cleavage
[5,6]. Instead, inhibition occurs through steric hindrance
of the translation machinery [6], and potent antisense
effects can be obtained by targeting the mRNA start codon
region [7].
Here we examined the consequences of PNA-mediated
inhibition of cotranscribed gene expression in E. coli. The
separate mRNA start codon regions within both an artifi-
cial TU (gfp/DsRed) and the endogenous E. coli lac-operon
were targeted by antisense-PNAs followed by protein
quantifications for each ORF. Expression from the artifi-
cial gfp/DsRed construct was completely discoordinated,
as only GFP levels were reduced when the gfp start codon
region was targeted, and only RFP levels were reduced
when the start codon region of DsRed was targeted. How-
ever, a directional downstream expression inhibition of
the native lac-genes was observed. Interestingly, mRNA-
level measurements confirmed this expression pattern,
although inhibition was less pronounced than at the pro-
tein level. The main conclusion is that steric hindrance of
translation initiation affects cotranscribed genes to a vari-
able degree. Therefore, simple, specific methods for func-
tional studies on most bacterial genes are lacking.
Results
Antisense effects on genes within an artificial operon
To obtain a system producing polycistronic mRNA tran-
scripts where expression from cotranscribed ORFs is easily
quantified we inserted a stop codon between the gfp and
DsRed parts in the pGRFP double reporter plasmid [8].
Also, to improve prospects for translational coordination
between the genes, the intergenic distance was kept short
and a strong SD sequence was included [9]. The resulting
pGRFPsep construct (Figure 1, Figure 2A) was introduced
into E. coli AS19. After treatment with varying concentra-
tions of anti-gfp, anti-DsRed  or two unrelated control
PNAs (anti-lacZ and anti-lacY, see Table 1 for details) pro-
tein expression was determined. As seen in Figure 2B,
treatment with the anti-gfp PNAs resulted in a reduction of
GFP levels, whereas RFP levels remained largely unaf-
fected (upper panel). Similarly, the anti-DsRed PNAs only
reduced the expression of RFP (Figure 2B, middle panel).
Moreover, the control experiments with PNAs directed to
unrelated mRNA targets did not inhibit the expression of
GFP or DsRed (Figure 2B, lower panel). Therefore, the
results show a specific downregulation of expression even
though the coding sequences belong to the same tran-
scriptional unit.
Antisense effects on gene expression within the lac-operon
The above result describes the effect of antisense PNA tar-
geted to cotranscribed genes within a system where trans-
lation is discoordinated. However, as this system is an
Illustration of plasmid pGRFP-sep Figure 1
Illustration of plasmid pGRFP-sep. The parent green-
red fusion plasmid pGRFP [8] was modified by insertion of a 
gfp stop codon, a strong Shine-Dalgarno sequence and start 
codon for DsRed. pGRFP-sep expresses gfp and DsRed as one 
transcript encoding two different proteins.BMC Microbiology 2006, 6:97 http://www.biomedcentral.com/1471-2180/6/97
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Expression of GFP and DsRed from an artificial polycistronic transcript after treatment with anti-gfp and anti-DsRed PNA Figure 2
Expression of GFP and DsRed from an artificial polycistronic transcript after treatment with anti-gfp and anti-
DsRed PNA. (A) Structure of the artificial gfp/DsRed-operon with the antisense target sites indicated by a small arrows. (B) 
Relative amounts of GFP (left panel) and DsRed (right panel) in cells after treatment with increasing concentrations of anti-gfp 
(top), anti-DsRed (center) and controls consisting of anti-lacZ and anti-lacY PNAs (bottom). For treatment with anti-gfp and 
anti-DsRed PNAs, squares and triangles represent values for two different antisense sequences that share genetic targets. For 
the control experiments, squares represent treatment with anti-lacZ PNA and triangles treatment with anti-lacY PNA. All data 
points are derived from six double samples using non-treated cells as standard and pGRFPsep-free cells to remove background 
fluorescence.BMC Microbiology 2006, 6:97 http://www.biomedcentral.com/1471-2180/6/97
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artificial construct lacking naturally evolved regulatory
components and sequences we decided to continue the
study with an endogenous operon. We targeted the genes
in the chromosomally expressed lac-operon and deter-
mined the effect on the expression of its three structural
genes; lacZ, lacY and lacA (see Figure 3A). Treatment with
anti-lacZ PNA resulted in a strong inhibition of the lacZ
encoded protein (Figure 3B). Also, expression from the
two downstream genes lacY  and  lacA  was markedly
reduced, however not to the same extent as lacZ expres-
sion. When bacteria were incubated with anti-lacY PNA,
lacY  and  lacA  gene expression was reduced, whereas
expression from the upstream lacZ gene was unaffected
(Figure 3C). Unfortunately, we did not obtain any data
with anti-lacA PNA as this displayed strong growth inhib-
itory effects. Nevertheless, the results show that antisense
targeted to an upstream gene in the lac-operon has a large
impact on the expression from the downstream genes. In
contrast, no upstream coordination was observed, sug-
gesting a directional inhibitory effect in the lac-operon.
To ensure that the anti-lacZ and anti-lacY PNAs did not
interfere with bacterial growth and examine whether
expression of an unrelated protein was affected by the
presence of antisense, we determined growth rate and Lux
activity in cells carrying the plasmid pLux1 following
treatment with PNAs that target the lac-operon. Neither
growth nor Lux expression was altered by the PNAs when
added in concentrations up to 1000 nM (see Additional
file 1).
Antisense effect on mRNA levels
To better understand the expression pattern observed at
the protein level, we used quantitative real time PCR
(qPCR) to study the impact of antisense PNA inhibition at
the mRNA level. Samples from bacteria treated with vary-
ing concentrations of either anti-lacZ (0, 200 and 400 nM)
or anti-lacY PNA (0, 100 and 200 nM) were analysed for
their lacZ and lacY mRNA content (Figure 4). Treatment
with anti-lacZ PNA significantly reduced lacZ mRNA at
both 200 nM and 400 nM (p < 0.01 and p < 0.001, respec-
tively) (Figure 4A). LacY mRNA was less affected and a sig-
nificant reduction was only obtained with the higher anti-
lacZ PNA concentration (p < 0.05). Moreover, there was a
significantly higher reduction of lacZ  mRNA than lacY
mRNA after treatment with the lower antisense dose (p <
0.05), but not at the higher dose (p = 0.066). Interestingly,
a comparison between protein and mRNA levels after
anti-lacZ PNA treatment reveals a coupled reduction (cf.
Figure 3B with 4A). Anti-lacY PNA significantly reduced
the level of lacY mRNA at both 100 and 200 nM concen-
trations (p < 0.05 and p < 0.005, respectively), whereas
lacZ mRNA levels were comparable to untreated cells (Fig-
ure 4B). Again, a coupled reduction of transcript and pro-
tein levels is demonstrated as LacY but not LacZ protein
concentrations were reduced by anti-lacY PNA (cf. Figure
3C with 4B).
The above results demonstrate a dose dependent gene
expression inhibition at both the mRNA and protein lev-
els, with a proportionally stronger reduction of protein.
To further examine this relationship we performed a more
detailed analysis of lacZ gene expression with anti-lacZ
PNA doses ranging from 0 to 400 nM concentrations at 50
nM intervals. Again, a coupled reduction of both protein
and mRNA levels was observed (Figure 5A). Supporting
our previous observations (Figure 3B and Figure 4A),
increasing doses of anti-lacZ PNA resulted in a negative
exponential decrease in LacZ protein activity whereas the
decrease in lacZ mRNA was linear (Figure 5B).
Discussion
The aim of this study was to examine antisense PNA medi-
ated inhibitory effects when genes in polycistronic oper-
ons are targeted. We demonstrate that protein expression
from cotranscribed genes can be substantially inhibited
by antisense and that there is a stringent coupling between
protein and transcript levels when ribosomal binding is
hindered.
We first demonstrate that antisense PNAs directed to the
mRNA start codon region of either gene in an artificial gfp-
DsRed dual reporter operon lead to a fully discoordinated
reduction in gene expression. This was followed by target-
Table 1: PNA structures and mRNA target sites
PNA Structure Target site
anti-gfpI (KFF)3K-eg1-aataacctcc -11 to -2
anti-gfpII (KFF)3K-eg1-cgcataaata -5 to +5
anti-DsRedI (KFF)3K-eg1-attctgtttcc -9 to +2
anti-DsRedII (KFF)3K-eg1-ccattctgtt -6 to +4
anti-lacZ (KFF)3K-eg1-catagctgtttc -9 to +3
anti-lacY (KFF)3K-eg1-cataatggattt -9 to +3
anti-lacA (KFF)3K-eg1-caatgcgatc -7 to +3
mRNA target sites are shown relative to translation start sites of the respective coding sequences.BMC Microbiology 2006, 6:97 http://www.biomedcentral.com/1471-2180/6/97
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ing the separate genes in the chromosomally encoded lac-
operon. Interestingly, in this case a different response to
antisense PNA mediated translational inhibition was
observed. Targeting the 5' lacZ resulted in a stronger inhi-
bition of LacZ than the downstream LacY and LacA pro-
teins, demonstrating a partial discoordination in protein
expression, a phenomena previously observed by Pestka
and co-workers when "anti-mRNA" directed to lacZ
mRNA was expressed from a plasmid [10]. When lacY was
targeted, downstream LacA expression was reduced as
much as LacY, whereas LacZ was unaffected. The general
differences in expression response between the gfp-DsRed
transcript and the lac-operon transcript can likely be
assigned to differences in expression regulation: For the
naturally occurring lac-transcript, and also for many other
endogenously expressed polycistronic transcripts, a vari-
ety of regulatory mechanisms have evolved to balance
gene expression according to the cell's needs. The gfp-
DsRed transcript, however, is not a natural component for
bacteria and is therefore not likely to be affected by such
specific regulatory mechanisms. Therefore we conclude
that antisense PNAs targeted to genes belonging to poly-
cistronic transcripts are very likely to affect cotranscribed
genes, thereby rendering gene functional studies on such
genes more difficult.
Several studies show that efficient ribosomal binding is
necessary for bacterial mRNA stability [11-13], and that
actively translating ribosomes protect mRNA from RNase
E mediated decay [14]. Also, it has been shown that
enhanced transcription rates of lacZ  mRNA lead to
decreased production of LacZ protein and lower transcript
stability, probably due to prolonged exposure of unpro-
tected mRNA behind the RNA polymerase [15]. Antisense
PNAs inhibit gene expression by steric hindrance of the
translation machinery and the effect is most potent when
targeting mRNA ribosome binding sites [6,7]. By blocking
ribosome loading, antisense PNA may have an effect on
mRNA levels. Therefore, we investigated the impact of
anti-lacZ and anti-lacY PNA on mRNA. We observed that
the pattern of mRNA levels following antisense treatment
was similar to that of protein levels within the lac-operon,
suggesting that inhibition of translation by antisense PNA
indeed has a destabilising effect on mRNA. Destabilisa-
tion of target mRNA is in accordance with that observed
by Forsyth and co-workers when they used expressed anti-
sense RNA to down-regulate gene expression [16]. There-
fore, it appears that the activity of sterically blocking
antisense agents, at least in some cases, can be assessed by
examining the mRNA levels. The reason for this coupling
of mRNA and protein levels is likely due to an increased
exposure/decreased protection of the mRNA.
The altered expression pattern of the lac  genes as a
response to antisense treatment raises at least two new
Protein expression from the lac-operon after treatment with  antisense PNA directed to lacZ and lacY mRNA start codon  regions Figure 3
Protein expression from the lac-operon after treat-
ment with antisense PNA directed to lacZ and lacY 
mRNA start codon regions. (A) Structure of the lac-
operon with antisense target sites on the mRNA indicated by 
small arrows. The solid bars below indicate amplified regions 
in subsequent qPCR experiments. Relative amounts of LacZ 
(triangles), LacY (squares) and LacA protein (diamonds) were 
detected in cultures induced with 100 µM IPTG and treated 
with increasing concentrations of either anti-lacZ (B) or anti-
lacY PNA (C). Data points show the mean from triplicate 
samples where non-treated samples are used as standard and 
un-induced samples are used to remove noise from the 
assays.BMC Microbiology 2006, 6:97 http://www.biomedcentral.com/1471-2180/6/97
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questions: (i) "Why is expression from the downstream
lacY and lacA less inhibited than lacZ with anti-lacZ PNA?"
and (ii) "How can lacZ  expression remain unaffected
when cells are treated with anti-lacY PNA?" If one only
considers protein expression levels it would be possible to
explain the partly discoordinated downstream inhibition
as being due to noise in the LacY and LacA assays. How-
ever, standard curves created with different mixtures of
induced and non-induced cells gave linear responses
(data not shown). Moreover, mRNA quantification exper-
iments revealed a coupled pattern between transcript and
protein levels when antisense was added. An alternative
explanation could be that reinitiation at nearby start
codons after a ribosome has reached the stop of a coding
region is somehow affected in a polar manner. However,
it has been demonstrated that reinitiation of ribosomes is
a comparatively rare event during translation [9,17], an
observation also supported here by our results from the
double reporter experiment. It is therefore unlikely that
altered reinitiation could explain the rather large expres-
sion differences between LacZ and LacYA. Also, the effect
on mRNA suggests a different explanation. We believe the
explanation may lie in direct inhibition of LacZ protein
synthesis together with Rho-dependent premature tran-
scription termination. Cessation of translation induces
Rho-dependent termination, probably due to increased
exposure of Rho protein binding sites behind the tran-
scribing RNA polymerase [18]. As it has previously been
shown that the lacZ coding region contains several Rho
binding sites [19], antisense inhibition of ribosome bind-
ing at the lacZ mRNA should lead to increased Rho bind-
ing and therefore increased premature transcription
termination. However, as translation inhibition of, in this
case, LacZ is the primary event; premature transcription
termination is expected to be slightly delayed. Indeed,
such a tendency can be observed at both protein and
mRNA levels following antisense inhibition (Figure 3B
and 4A). Moreover, the analysis using a more detailed
anti-lacZ PNA dose range confirms this pattern (Figure 5):
While mRNA amounts decreased linearly with increasing
concentrations of anti-lacZ PNA the decrease in LacZ pro-
tein activity was much more pronounced.
Why, then, is lacZ not affected by downstream targeting
by the anti-lacY  PNA? Even though the lac-operon is
thought to be fully transcribed before being processed
[20], it has been observed that lacZ transcripts are several
folds more abundant than ZYA transcripts [20,21]. This
imbalance can be explained by RNase E cleavage within
the lacZY intergenic region that stabilises the lacZ portion
of the transcript [22], an event that decouples the coding
regions of lacZ and lacYA [23]. According to this model,
Relative amounts of lacZ and lacY mRNA species after antisense PNA treatment Figure 4
Relative amounts of lacZ and lacY mRNA species after antisense PNA treatment. Levels of specific mRNAs were 
determined using real time PCR with 16S rRNA as an internal control. Mean delta Ct values (target-rRNA) were compared 
across concentrations of anti-lacZ and anti-lacY PNAs using unpaired t-tests assuming equal variance among groups. Significance 
was set at p < 0.05 and error bars reflect standard deviation. (A) Samples from cells treated with 0, 200 and 400 nM concen-
trations of anti-lacZ PNA. (B) Samples from cells treated with 0, 100 and 200 nM concentrations of anti-lacY PNA.BMC Microbiology 2006, 6:97 http://www.biomedcentral.com/1471-2180/6/97
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most of the LacZ product is likely to be translated from
processed monocistronic transcripts that can not be
affected by antisense binding to lacY mRNA.
Conclusion
In summary, our experiments show that antisense inhibi-
tion of genes within polycistronic operons can strongly
affect cotranscribed genes. We further show that inhibi-
tion is followed by a decreased stability of the transcript
that is coupled with translational reduction. This
decreased mRNA stability can not be explained by RNase
H activity because antisense PNA do not induce such
cleavage. Instead, we believe that the presence of antisense
unmasks the mRNA from translating ribosomes and
thereby increases exposure to RNase cleavage and intrinsic
decay mechanisms that regulate RNA stability. A practical
issue associated with the stringent correlation between
transcript and protein levels is that mRNA quantification
may provide an additional measure of specificity for anti-
sense experiments, at least for targets susceptible to rapid
degradation when unprotected. Also, the antisense based
methodology described here can be helpful for investiga-
tions of bacterial mRNA translation and stability. Never-
theless, the dependence of protein expression on mRNA
structure and stability indicate that simple and specific
methods for functional studies on the majority of bacte-
rial genes are still lacking. Therefore, we suggest that anti-
sense and other strategies for bacterial gene expression
inhibition as a means for gene functional studies [24-26]
and drug screening [16,27] should be performed with
extra caution with respect to cotranscribed genes.
Methods
Bacterial strain and PNAs
E. coli strain AS19 was used throughout this study. Due to
its hyper permeable nature lower antisense concentra-
tions are required for gene expression inhibition in this
strain. PNAs were designed to target the start codon
regions of gfp, luc, lacZ and lacY (and lacA), with the pep-
tide (KFF)3K attached for improved cellular uptake [28]
and were obtained from Panagene (Daejeon Metropolitan
City, Korea). Peptide-PNA sequences are listed in Table 1.
Importantly, none of the peptide-PNAs (except anti-lacA
PNA) displayed any alteration in bacterial growth under
the conditions and with the concentrations used in this
study.
Construction of a polycistronic pGRFP-sep plasmid
Cloning vector pGRFP [8] expressing GFP and DsRed as a
fusion protein was kindly provided by Stephanie Mohr at
Dana-Farber/Harvard Cancer Center DNA Resource Core,
US. A GFP stop codon, a BglII cleavage site, a Shine-Dal-
garno sequence and a unique PNA binding site were intro-
duced between gfp and DsRed using upstream primer 5'-
gcgagatctcatttgtatagttcatccatgccatgtgtaatcccagcagc-3' and
Dose effect of antisense PNA on LacZ protein activity and  lacZ mRNA abundance Figure 5
Dose effect of antisense PNA on LacZ protein activ-
ity and lacZ mRNA abundance. AS19 cells induced with 
100 µM IPTG and treated with increasing concentrations of 
anti-lacZ PNA were harvested at ∆OD550 < 0.1 for LacZ 
activity and RT-PCR measurements. (A) Relative amounts of 
LacZ protein (hatched bars) and lacZ mRNA (slashed bars) 
are shown as mean values from three separate experiments 
+/- std. Nontreated samples were used as standard and un-
induced samples were used to remove background. (B) Non-
linear correlation between LacZ activity and mRNA abun-
dance after treatment with anti-lacZ PNA at increasing 
concentrations. The average values shown in panel (A) were 
plotted following log transformation of the LacZ activity data. 
Linear regression analysis of the plotted data indicates R = 
0.974 for the correlation with the two tailed p < 0.001.BMC Microbiology 2006, 6:97 http://www.biomedcentral.com/1471-2180/6/97
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downstream primer 5'-tatagatctaaggaggaaacagaatggcctc-
ctccgaggacgtcatca-3'. Cleavage with BglII  and ligation
yielded pGRFPsep, expressing gfp and DsRed as a single
mRNA encoding two different proteins (Figure 1).
pGRFPsep was transformed into E. coli AS19 where the
double reporter system was constitutively expressed.
Simultaneous assay of GFP and RFP
E. coli AS19 and AS19/pGRFPsep were grown for around
12 h in 2 ml Mueller Hinton (MH) broth at 37°C with
constant shaking at 225 rpm. Optical density (OD) was
measured at 550 nm and the cultures were diluted to 1.25
× 106 bacteria per ml in MH. Aliquots (80 µl) were added
to the wells of a 96 well plate (COSTAR® 3474, Corning
Inc., NY). Plates were incubated in a VERSAmax spectro-
photometer (Molecular Devices Corporation, CA, USA) at
37°C with shaking and OD measurements taken each five
minutes. When OD550 had increased by ~0.025, dilutions
of anti-gfp or anti-DsRed PNAs were added to make total
culture volumes of 100 µl. PNAs directed to lacZ and lacY
mRNA were also included to provide controls. Cultures
were harvested in late logarithmic phase after an increase
in OD550 of ~0.1.
For GFP/DsRed level determinations, AS19 and AS19/
pGRFP-sep were lysed by mixing 50 µl cell samples with
50 µl lysis buffer (Pierce Biotechnology, prod. no. 78990)
in a 96-well assay plate ("Costar 3632", Corning Inc.).
Fluorescence measurements were carried out in a NOVOs-
tar fluorescence/luminescence reader (BMG Labtechnolo-
gies, NC, USA). Lysates were excited at 485/560 nm and
fluorescence emission was detected at 520/590 nm. Total
fluorescence was determined by 100 flashes with maxi-
mum capacity of 65000 relative fluorescence units (RFU).
Background fluorescence was determined with plasmid
free AS19 cell lysates.
Simultaneous assay of beta-galactosidase, lactose 
permease and thiogalactoside transacetylase
E. coli AS19 cells were pre-grown overnight in 2 ml MH
broth at 37°C with constant shaking at 225 rpm. Cultures
were diluted to 1.25 × 106 bacteria per ml in MH and aliq-
uots (200 µl) corresponding to approximately 2.5 × 105
cells were added to the wells of a 96 well plate. Dilutions
of PNAs were added together with IPTG to make a total
culture volume of 250 µl with 100 µM IPTG. IPTG- and
PNA-free cultures were used as controls. Plates were incu-
bated in a VERSAmax spectrophotometer 37°C with shak-
ing and OD measurements each five minutes until an
increase in OD550 of ~0.1 was reached. Samples of the cul-
tures were treated as follows:
LacZ assay
Samples of E. coli cultures (20 µl) were mixed with 20 µl
lysis buffer and incubated one hour at room temperature.
Beta-galactosidase content of the samples was determined
by addition of 160 µl Z-buffer and 20 µl ONPG solution
[29], followed by kinetic spectrophotometric measure-
ments of colour conversion at 420 nm every 30 s with 5 s
shaking. Curve slopes were used to determine relative lev-
els of beta-galactosidase activity in the samples.
LacY assay
Aliquots of 150 µl culture were mixed with 20 µl chloram-
phenicol to give a final 150 µg/ml antibiotic concentra-
tion. Samples were incubated on ice for 10 min and 150
µl were transferred to 96-well plates containing 50 µl 14C-
lactose (10 µM final concentration). After incubation at
37°C with shaking every five minutes for 30 min, cells
were applied to a glass fiber filter (PerkinElmer, prod. no:
1450-441) and washed with PBS in a TOMTEC (Tomtec
Inc., Hamden, CT, USA) cell harvester. The filter was dried
in a microwave oven, placed in a sample bag (prod. no:
1450-432) together with a Meltilex A melt-on scintilator
sheet (prod. no: 1450-441) and sealed in a Heatsealer
(PerkinElmer). Lactose permease mediated uptake of 14C
labelled lactose was detected in a Wallac 1450 MicroBeta®
TriLux scintillation counter.
LacA assay
Aliquots of 50 µl culture were transferred to 50 µl lysis
buffer and incubated at room temperature for 20 minutes.
Samples were kept at 70°C for 5 min before a 15 min cen-
trifugation at 20800 g in RT. Supernatants (50 µl) were
transferred to 10 µl assay media (5 mg/ml acetyl CoA and
250 mg/ml IPTG in 0.05 M Tris and 0.01 M EDTA, pH
7.9) followed by a one hour incubation at 25°C. Addition
of 200 µl DTNB solution (250 µg/ml in 0.05 M Tris pH
7.9) was followed by OD-measurement at 412 nm to
determine relative amounts of lacA gene product.
Controls and standard curves were provided for all assays
using un-induced AS19 cells and/or mixtures of un-
induced and induced cells.
An additional control for anti-lacZ and anti-lacY PNA spe-
cificity was performed on AS19 cells carrying plasmid
pLux1 [31] that contains the luxA and luxB genes from
Vibrio harveyi. Cells were grown under the same condi-
tions as in the lac-assays with increasing concentrations
(0–1000 nM) of anti-lacZ  and anti-lacY  PNA. Cultures
were either allowed to grow continuously for generating
growth curves or harvested after an increase in OD550 of
~0.1 cells for quantification of luciferase expression fol-
lowing a previously described protocol [32]. Plasmid-free
AS19 were used to remove background luminescence.BMC Microbiology 2006, 6:97 http://www.biomedcentral.com/1471-2180/6/97
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mRNA quantification by reverse transcription and real 
time PCR
E. coli AS19 treated with different concentrations of anti-
lacZ or anti-lacY PNA in the presence or absence of 100
µM IPTG were incubated until the OD550 increased by
~0.1. Cells with equal treatment were pooled to get two
separate 1 ml samples for each treatment. Total RNA was
extracted with TRIZOL®Reagent following the manufac-
turer's instructions (Invitrogen). Samples were dissolved
in 34 µl RNase-free water (Invitrogen) and treated with
RNase-free DNase (Sigma Aldrich). RNA concentrations
were determined by OD-readings on an Ultrospec 3000
(Pharmacia Biotech, Uppsala, Sweden). Reverse transcrip-
tion was performed using random hexamers with 1 µg
RNA in 50 µl reactions following the manufacturers pro-
tocol (Applied Biosystems). Aliquots derived from 50 ng
RNA were analyzed by qPCR on an ABI PRISM 7000
(Applied Biosystems) according to the manufacturers pro-
tocol. Samples were run in triplicates and the data
obtained were analyzed with ABI Prism SDS Software
(Applied Biosystems). The ∆∆Ct method was used to cal-
culate lacZ and lacY gene expression using rRNA as an
internal standard [30]. Sequences for the lacZ and lacY
primers were selected to amplify regions near the 5' end of
the coding regions to increase the chances of detecting
functional transcripts as lac mRNAs are degraded in a 5' to
3' direction [20,33], and were: lacZ forward 5'-ccctggcgt-
tacccaacttaa-3'; lacZ reverse 5'-gcgggcctcttcgctattac-3'; lacY
forward 5'-cgcaaatacctgctgtggatta-3' and lacY  reverse 5'-
tggcccgaagataaaaataaagaa-3'. The primer binding sites did
not interfere with antisense PNA target sites (see Figure
3A). Primer sequences for rRNA were taken from [34] and
were: rRNA forward 5'-catgccgcgtgtatgaagaa-3' and rRNA
reverse 5'-cgggtaacgtcaatgagcaaa-3'. RNA isolation and
quantification was repeated at four different occasions
giving eight samples and 24 data points per PNA concen-
tration. Data comparisons were made to a normalised
control value obtained by calculating the mean at each
experimental occasion. Statistical calculations were per-
formed in Excel using unpaired t-tests assuming equal var-
iance among groups and data are presented as the mean
with error bars reflecting the standard deviation. Signifi-
cance was set at p < 0.05.
Parallel analysis of LacZ activity and lacZ mRNA 
abundance
E. coli AS19 treated with anti-lacZ  PNA concentrations
ranging from 0 to 400 nM at 50 nM intervals were grown
in six double replicas in the presence or absence of 100
µM IPTG. Cultures were incubated under the same condi-
tions as described above and harvested when OD550 had
increased by ~0.1. Samples of 20 µl were removed from
each well to be used for separate LacZ activity measure-
ments as described above, and the remainder of the cul-
tures were pooled into groups with equal treatment. Total
RNA was extracted and treated with DNase I using RiboP-
ure Bacteria kit (Ambion), according to the manufac-
turer's protocol. Quantification of lacZ  mRNA was
performed as described above. Mean values from the six
replicates of each treatment were used to determine rela-
tive LacZ activity and the averages of three replicates
derived from each sample pool were used to estimate
mRNA abundance. The experimental procedure was
repeated at three different occasions, and mean values
with error bars were plotted as a histogram. Regression
analysis was conducted using VassarStats [35].
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